BioRestorative Therapies (BRTX) EBIT Margin (2012 - 2025)
BioRestorative Therapies' EBIT Margin was -19516.84% in Q4 2025, down 13304.04 percentage points from -6212.80% a year earlier but up 11915.46 percentage points from the prior quarter.
Powered by 
Analysis
BioRestorative Therapies (BRTX) EBIT Margin (2012 - 2025) Analysis & Trends
For FY2025, EBIT Margin at BioRestorative Therapies came in at -4350.05%, down 1468.46 percentage points from FY2024.
- EBIT Margin shows a five-year change of -775.93 percentage points (FY2020 to FY2025).
- In earlier years, EBIT Margin was -2881.59% in FY2024 (+7557.89 pp), -10439.49% in FY2023 (+5398.60 pp), -15838.08% in FY2022 (+41352.94 pp) and -57191.03% in FY2021 (-53616.90 pp).
- Quarterly EBIT Margin has moved between -126537.95% (Q4 2022) and -979.02% (Q3 2024) over five years.
- Compared with a year earlier, EBIT Margin was higher in five of the last eight quarters, with an average year-over-year change of -2646.74 percentage points.
- The best year-over-year quarter for EBIT Margin over five years was Q4 2023 (a gain of 109850.47 percentage points); the worst was Q1 2021 (a drop of 80487.02 percentage points).
- Per Business Quant data, BRTX's EBIT Margin in the three quarters before Q4 2025 was -31432.30% (Q3 2025), -1089.77% (Q2 2025) and -19230.14% (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 37.40% |
| 10 | BioRestorative Therapies | 1.03 Mn | -22.90 Mn | 17,964.00 | -19,516.84% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -19,516.84% |
| Sep 30, 2025 | -31,432.30% |
| Jun 30, 2025 | -1,089.77% |
| Mar 31, 2025 | -19,230.14% |
| Dec 31, 2024 | -6,212.80% |
| Sep 30, 2024 | -979.02% |
| Jun 30, 2024 | -2,770.83% |
| Mar 31, 2024 | -11,740.72% |
| Dec 31, 2023 | -16,687.47% |
| Sep 30, 2023 | -10,112.19% |
| Jun 30, 2023 | -4,831.86% |
| Mar 31, 2023 | -18,463.57% |
| Dec 31, 2022 | -126,537.95% |
| Sep 30, 2022 | -15,895.52% |
| Jun 30, 2022 | -6,510.03% |
| Mar 31, 2022 | -31,586.21% |
| Dec 31, 2021 | -80,185.34% |
| Sep 30, 2021 | -46,108.59% |
| Jun 30, 2021 | -23,701.75% |
| Mar 31, 2021 | -83,636.98% |
API Access
BioRestorative Therapies EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=BRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "BRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=BRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();